Literature DB >> 11082482

Diurnal metabolism of dopamine in dystrophic retinas of homozygous and heterozygous retinal degeneration slow (rds) mice.

I Nir1, R Haque, P M Iuvone.   

Abstract

Dopamine metabolism was studied in dystrophic retinal degeneration slow (rds) mice which carry a mutation in the rds/peripherin gene. RDS mutations in humans cause several forms of retinal degeneration. Dopamine synthesis and utilization were analyzed at various time points in the diurnal cycle in homozygous rds/rds retinas which lack photoreceptor outer segments and heterozygous rds/+ retinas which have short malformed outer segments. Homozygous retinas exhibited depressed dopamine synthesis and utilization while the heterozygous retina retained a considerable level of activity which was, nevertheless, significantly lower than that of normal retinas. By one year, heterozygous rds/+ retinas which had lost half of the photoreceptors still maintained significant levels of dopamine metabolism. Normal characteristics of dopamine metabolism such as a spike in dopamine utilization at light onset were observed in mutant retinas. However, light intensity-dependent changes in dopamine utilization were observed in normal but not rds/+ retinas. The findings of this study suggest that human patients with peripherin/rds mutations, or other mutations that result in abnormal outer segments that can still capture light, might maintain light-evoked dopamine metabolism and dopamine-dependent retinal functions during the progression of the disease, proportional to remaining levels of light capture capabilities. However, visual deficits due to reduced light-evoked dopamine metabolism and abnormal patterns of dopamine utilization could be expected in such diseased retinas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11082482     DOI: 10.1016/s0006-8993(00)02855-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Dopamine D₄ receptor activation controls circadian timing of the adenylyl cyclase 1/cyclic AMP signaling system in mouse retina.

Authors:  Chad R Jackson; Shyam S Chaurasia; Christopher K Hwang; P Michael Iuvone
Journal:  Eur J Neurosci       Date:  2011-06-16       Impact factor: 3.386

2.  Pgc-1α and Nr4a1 Are Target Genes of Circadian Melatonin and Dopamine Release in Murine Retina.

Authors:  Stefanie Kunst; Tanja Wolloscheck; Debra K Kelleher; Uwe Wolfrum; S Anna Sargsyan; P Michael Iuvone; Kenkichi Baba; Gianluca Tosini; Rainer Spessert
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

3.  An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration.

Authors:  J Lahdenranta; R Pasqualini; R O Schlingemann; M Hagedorn; W B Stallcup; C D Bucana; R L Sidman; W Arap
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

4.  Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.

Authors:  Kathryn G Schuff; Shane T Hentges; Michele A Kelly; Nadine Binart; Paul A Kelly; P Michael Iuvone; Sylvia L Asa; Malcolm J Low
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 5.  Circadian regulation in the retina: From molecules to network.

Authors:  Gladys Y-P Ko
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

Review 6.  Dopamine and retinal function.

Authors:  Paul Witkovsky
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

Review 7.  Melatonin: an underappreciated player in retinal physiology and pathophysiology.

Authors:  Gianluca Tosini; Kenkichi Baba; Christopher K Hwang; P Michael Iuvone
Journal:  Exp Eye Res       Date:  2012-08-31       Impact factor: 3.467

8.  Neonatal aphakia is associated with altered levels of dopamine metabolites in the non-human primate retina.

Authors:  P Michael Iuvone; Rashidul Haque; Alcides Fernandes; Scott R Lambert
Journal:  Exp Eye Res       Date:  2015-09-11       Impact factor: 3.467

9.  The rat with oxygen-induced retinopathy is myopic with low retinal dopamine.

Authors:  Nan Zhang; Tara L Favazza; Anna Maria Baglieri; Ilan Y Benador; Emily R Noonan; Anne B Fulton; Ronald M Hansen; P Michael Iuvone; James D Akula
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-19       Impact factor: 4.799

10.  Increased phosphorylation of Cx36 gap junctions in the AII amacrine cells of RD retina.

Authors:  Elena Ivanova; Christopher W Yee; Botir T Sagdullaev
Journal:  Front Cell Neurosci       Date:  2015-10-01       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.